Overall rank by patents
#10,329
Across all tracked assignees
USPTO PatentsView assignee record - 30 granted patents across 15 technology areas, active 2015–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).
The verdict
Genapsys holds 30 US patents across 15 technology areas, rank #10,329 of 50,000 tracked assignees.
Genapsys, Inc. has been granted 30 US utility patents between 2015 and 2022, placing Genapsys, Inc. at rank #10,329 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.9 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a US Corporation, Genapsys, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Genapsys sits between Fuel Automation Station, Llc (30 patents, rank #10,325) and Gatik AI Inc. (30 patents, rank #10,333) - the closest US assignees by grant volume. The composite Innovation Score of 39.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 12 grants, compared with 18 in the 2015–2019 window, a -33% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Genapsys, Inc.'s 21.9 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 15 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Genapsys, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Fuel Automation Station, LLC
30 patents
Furcifer Inc.
30 patents
GE Oil & Gas Compression Systems, LLC
30 patents
GE Vernova Infrastructure Technology LLC
30 patents
GIBSON INNOVATIONS BELGIUM N.V.
30 patents
GRIFOLS, S.A.
30 patents
GUANGZHOU BAOMEI NETWORK TECHNOLOGY CO., LTD.
30 patents
Gatik AI Inc.
30 patents
GENAPSYS, INC.
30 patents
What this shows Genapsys holds 30 patents at rank #10,329, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #10,329 in granted patent volume.
Other assignees with the most granted patents in Genapsys's primary technology class.
Genapsys's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
40 Top 38% higher than 62% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 10.0% |
| 2016 | 2 | 6.7% |
| 2017 | 4 | 13.3% |
| 2018 | 4 | 13.3% |
| 2019 | 5 | 16.7% |
| 2020 | 6 | 20.0% |
| 2021 | 4 | 13.3% |
| 2022 | 2 | 6.7% |
Top 15 of 15 technology areas
Overall rank by patents
#10,329
Across all tracked assignees
39.6 out of 100
How to use this portfolio
Genapsys's 30 grants land it in the top 38% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.